SCHEMBL28688992

SCHEMBL28688992

NC(=O)Oc1ccc(Cl)c(N)c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.53
KMT2A Q03164 1/20 0.53
CA12 O43570 1/20 0.45
CA1 P00915 1/20 0.45
CA2 P00918 1/20 0.45
CA7 P43166 1/20 0.45
CA9 Q16790 1/20 0.45
CA14 Q9ULX7 1/20 0.45
TP53 P04637 1/20 0.43
TSHR P16473 1/20 0.43
KIF11 P52732 1/20 0.40
DRD4 P21917 1/20 0.38
KDM4E B2RXH2 2/20 0.37
NPC1 O15118 1/20 0.36
RAB9A P51151 1/20 0.36
ALDH1A1 P00352 2/20 0.36
NR1H4 Q96RI1 2/20 0.36
HPGD P15428 1/20 0.36
HSD17B10 Q99714 1/20 0.36
SLC9A1 P19634 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10892274 0.86 CA12 (0.47) MEN1KMT2ACA12CA1CA2
SCHEMBL11567274 0.85 CA12 (0.45) MEN1KMT2ACA12CA1CA2
SCHEMBL23753577 0.84 MEN1 (0.57) MEN1KMT2ACA12CA1CA2
SCHEMBL27593853 0.83 LMNA (0.47) MEN1KMT2ACA12CA1CA2
SCHEMBL28890049 0.81 MEN1 (0.53) MEN1KMT2ACA12CA1CA2
SCHEMBL10893735 0.80 KDM4E (0.49) MEN1KMT2AKDM4ENPC1RAB9A
SCHEMBL5260935 0.79 MEN1 (0.52) MEN1KMT2AKIF11
SCHEMBL23753572 0.79 MCL1 (0.56) MEN1KMT2AKDM4ENPC1RAB9A
SCHEMBL17242255 0.77 MEN1 (0.53) MEN1KMT2ACA1CA2TSHR
SCHEMBL14543275 0.77 KMT2A (0.53) MEN1KMT2ATSHRKIF11KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113754591-A HDAC, JAK and BET three-target inhibitor and preparation method and application thereof 山东大学 2021-12-07 CN disclosed
CN-109071543-B Pyridine derivatives inhibiting RAF kinase and vascular endothelial growth factor receptor, process for their preparation, pharmaceutical compositions containing them and their use 三进制药株式会社 2021-07-16 CN disclosed